Hikma Pharmaceuticals PLC (FRA:H5P)
Germany flag Germany · Delayed Price · Currency is EUR
18.70
0.00 (0.00%)
At close: Feb 20, 2026

Revenue by Segment

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016FY 2015
Period Ending
Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 Dec '18 Dec '17 Dec '16 Dec '15
Injectables
1.31B1.20B1.14B1.05B977.00M
Injectables Growth
8.56%5.53%8.26%7.78%9.28%
Branded
769.00M714.00M691.00M669.00M613.00M
Branded Growth
7.70%3.33%3.29%9.14%5.15%
Generics
1.03B937.00M672.00M820.00M744.00M
Generics Growth
9.50%39.43%-18.05%10.22%3.48%
Others
26.00M21.00M14.00M11.00M7.00M
Others Growth
23.81%50.00%27.27%57.14%-36.36%
Total
3.13B2.88B2.52B2.55B2.34B
Total Growth
8.77%14.22%-1.41%9.06%6.07%

Revenue by Geography

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016FY 2015
Period Ending
Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 Dec '18 Dec '17 Dec '16 Dec '15
North America (Excl. United States)
24.00M23.00M18.00M--
North America (Excl. United States) Growth
4.35%27.78%---
Other Middle East and North Africa
471.00M459.00M379.00M390.00M429.00M
Other Middle East and North Africa Growth
2.61%21.11%-2.82%-9.09%6.98%
Europe and Rest of the World
218.00M206.00M192.00M189.00M159.00M
Europe and Rest of the World Growth
5.83%7.29%1.59%18.87%30.33%
United Kingdom
13.00M11.00M8.00M6.00M6.00M
United Kingdom Growth
18.18%37.50%33.33%0%-14.29%
United States
1.89B1.73B1.43B1.51B1.41B
United States Growth
9.33%20.45%-5.16%7.47%3.46%
Saudi Arabia
301.00M261.00M240.00M218.00M223.00M
Saudi Arabia Growth
15.33%8.75%10.09%-2.24%9.31%
Algeria
213.00M189.00M132.00M112.00M-
Algeria Growth
12.70%43.18%17.86%--
Egypt
--115.00M127.00M118.00M
Egypt Growth
---9.45%7.63%3.51%
Total
3.13B2.88B2.52B2.55B2.34B
Total Growth
8.77%14.22%-1.41%9.06%6.07%
Source: S&P Global Market Intelligence.